CLINICAL_TRIALS
research
· 2026-04-16
Clinical Trial Update: Development and Evaluation of a Quantitative HP MRI for Clinical Prostate Cancer Exam
Summary
This ClinicalTrials.gov entry reports on the development and evaluation of a quantitative hyperpolarized MRI method for clinical assessment of prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Prostate Adenocarcinoma | Status: ACTIVE_NOT_RECRUITING